Golio is affiliated with Clarion Hospital, Penn Highlands Brookville and other hospitals.ġ. Urologist with Urology Services in Clarion, PA, with decades of diverse medical and teaching experience. Cohen has expertise in treating BPH, minimally invasive stone treatment, vasectomy, prostate cancer and robotic surgery.Į. Urologist in Libertyville, IL, who is Executive Vice President and Chief Compliance Officer for Uropartners, LLC, in Chicago. Rockove also holds faculty positions at local medical schools and was previously the Director of the Providence Portland Continence Program.ĭ. Urologist with the Center for Men’s and Women’s Urology in Gresham, OR. Highly experienced in laser and robotics surgery, Fagelson has expertise in treating prostate disease, including enlarged prostate (BPH) and prostate cancer.Ĭ. Urologist with the Urology Associates in Denver. Elterman’s clinical and research interests include male health, voiding dysfunction and reconstruction including BPH, incontinence, and sexual dysfunction.ī. Urologist with the University Urology Associates in Toronto and is on the faculty at the University of Toronto’s Division of Urology. Elterman: What are the cost differences?Ī.
Also, my patients say, “I hated the catheter, but I'm so thankful I did this procedure.” If the expectations are set, I find my patients are willing to put up with the catheter for a few days, maybe a few weeks of some irritative symptoms. Fagelson: I think once they see how easy it is, whether they've adopted UroLift or not, I think they'll start moving over to doing Rezūm Therapy. *NOTE: Dependent on individual clinical situation and healing response.
#Linked vallum investor relations chicago full
Once the catheter comes out in a week, they're back to full activity.* I’ve done over 40 patients and I've had no major side effects, no retreatments. Golio: Positive patient outcomes – patients are coming back happy after Rezūm Therapy, they're doing very well. If you would tell me that I can take care of a patient and only 4.4% of them might need surgery again, and 11.1% 1 of them might need medications again, I don't see what else could be more convincing than that.ĭr. Cohen: The Rezūm Therapy procedure works well, seems to cause fewer side effects, compared to those typically seen with surgical therapies, costs less to patients than other MITs or surgical therapies and it's easy to do it right there in the office. Elterman: Can you tell us about your initial experience with UroLift?ĭr. Dean Elterman, Assistant Professor, University of Toronto and Attending Urologist, University Health Network, Toronto, Canada, moderated a virtual roundtable discussion with four other urologists to explore their experiences with the UroLift System and Rezūm Therapy. Both procedures have long-term durability data up to five years. Rezūm Therapy is an in-office, minimally invasive procedure that uses water vapor thermal therapy (steam) to shrink the prostate. The UroLift System is an in-office, minimally invasive solution that involves the use of implants to hold open the obstructed pathway that’s blocking urine flow. Two MITs have recently come into prominence: UroLift™ Prostatic Urethral Lift System and Rezūm™ Water Vapor Therapy. When it comes to minimally invasive treatment (MIT) for benign prostatic hyperplasia (BPH), urologists are looking not only for good short-term results but also for long-term durability. Physician experience and patient responses can and do vary. Elterman, Fagelson, Cohen and Golio are Boston Scientific consultants and were compensated. The sentiments expressed within this article are representative of the opinions and experiences of the respective physicians.
0 kommentar(er)
